Testicular Cancer Global Clinical Trials Review, H2, 2013

  • November 2013
  • -
  • Global Data
  • -
  • 67 pages

Testicular Cancer Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H2, 2013" provides data on the Testicular Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Testicular Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Testicular Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Testicular Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Testicular Cancer 22
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Testicular Cancer Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
The EMMES Corporation 31
Clinical Trial Overview of The EMMES Corporation 31
ZIOPHARM Oncology, Inc. 32
Clinical Trial Overview of ZIOPHARM Oncology, Inc. 32
MannKind Corporation 33
Clinical Trial Overview of MannKind Corporation 33
GammaCan International Inc (Inactive) 34
Clinical Trial Overview of GammaCan International Inc (Inactive) 34
CellAct Pharma GmbH 35
Clinical Trial Overview of CellAct Pharma GmbH 35
Clinical Trial Overview of Top Institutes / Government 36
National Cancer Institute 36
Clinical Trial Overview of National Cancer Institute 36
Memorial Sloan Kettering Cancer Center 39
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 39
Fred Hutchinson Cancer Research Center 41
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 41
Medical Research Council 42
Clinical Trial Overview of Medical Research Council 42
The University of Texas M. D. Anderson Cancer Center 43
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 43
Southeastern Cancer Study Group 44
Clinical Trial Overview of Southeastern Cancer Study Group 44
Medical Research Council Clinical Trials Unit 45
Clinical Trial Overview of Medical Research Council Clinical Trials Unit 45
University Medical Center Groningen 46
Clinical Trial Overview of University Medical Center Groningen 46
Eastern Cooperative Oncology Group 47
Clinical Trial Overview of Eastern Cooperative Oncology Group 47
Wake Forest University 48
Clinical Trial Overview of Wake Forest University 48
Five Key Clinical Profiles 49
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 67



List of Tables

Testicular Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6
Testicular Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Testicular Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9
Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 10
Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 11
Testicular Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 12
Testicular Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 13
Testicular Cancer Therapeutics Clinical Trials, BRIC Countries, 2013* 14
Testicular Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 15
Testicular Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 16
Testicular Cancer Therapeutics Clinical Trials, E7 Countries, 2013* 17
Testicular Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 18
Testicular Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 19
Testicular Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 20
Testicular Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 21
Testicular Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2013* 22
Testicular Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23
Testicular Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24
Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
Testicular Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27
Testicular Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29
Testicular Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 30
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The EMMES Corporation, 2013* 31
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARM Oncology, Inc., 2013* 32
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2013* 33
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GammaCan International Inc (Inactive), 2013* 34
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by CellAct Pharma GmbH, 2013* 35
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 36
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 39
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2013* 41
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2013* 42
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 43
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Cancer Study Group, 2013* 44
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council Clinical Trials Unit, 2013* 45
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2013* 46
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2013* 47
Testicular Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2013* 48



List of Figures

Testicular Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6
Testicular Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Testicular Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9
Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 10
Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 11
Testicular Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 12
Testicular Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 15
Testicular Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 16
Testicular Cancer Therapeutics Clinical Trials, E7 Countries (%), 2013* 17
Testicular Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 19
Testicular Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 20
Testicular Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 21
Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
Testicular Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Testicular Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28
Testicular Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 30
GlobalData Methodology 65

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Diagnostics and Therapeutics for HIV: Global Markets

Diagnostics and Therapeutics for HIV: Global Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for products used in the treatment, testing ...

JAK and PI3K Signaling Pathway Markets

JAK and PI3K Signaling Pathway Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion ...

Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Learn about the main women's health disorders and relevant disease prevalence population. - Identify the impact of demographic, economic, and other factors that will drive future ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.